Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study.
Seok J, Koh YG, Hong JK, Yun SH, Kim DH, Son HS, Choi SY, Yoo KH, Lee YW, Kim BJ. Seok J, et al. Among authors: choi sy. Dermatol Surg. 2024 Jun 1;50(6):527-533. doi: 10.1097/DSS.0000000000004146. Epub 2024 Mar 8. Dermatol Surg. 2024. PMID: 38518110 Clinical Trial.
A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.
Choi SY, Koh YG, Lee YW, Son HS, Yoon YN, Kim G, Won C, Cho H, Son JS, Kim EK, Kim BJ. Choi SY, et al. J Dermatolog Treat. 2024 Dec;35(1):2359511. doi: 10.1080/09546634.2024.2359511. Epub 2024 Jun 16. J Dermatolog Treat. 2024. PMID: 38880494 Free article. Clinical Trial.
3,301 results